ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.330
-0.125 (-8.59%)
At close: Oct 16, 2026, 4:00 PM EDT
1.320
-0.010 (-0.75%)
After-hours: Oct 16, 2026, 7:58 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $402.09 million as of October 16, 2026. It is the 16,210th most valuable company in the world and the 2,897th biggest in the United States. Its market cap has decreased by 56.90% in one year.
Market Cap
402.09M
Enterprise Value
224.05M
1-Year Change
-56.90%
Global Rank
Country Rank
#2,897 United States
Category
ChartMarket Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $402.09M, an increase of 55.37%. That is a compound annual growth rate of 8.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 402.10M | -40.33% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 425.86M |
| Ovid Therapeutics | 419.89M |
| YD Bio | 419.32M |
| Assembly Biosciences | 409.04M |
| DiaMedica Therapeutics | 408.22M |
| AgomAb Therapeutics NV | 407.77M |
| Tectonic Therapeutic | 403.69M |
| Eikon Therapeutics | 401.90M |